US Stock MarketDetailed Quotes

TSHA Taysha Gene Therapies

Watchlist
  • 1.8300
  • -0.2000-9.85%
Close Dec 18 16:00 ET
375.05MMarket Cap2.90P/E (TTM)

Taysha Gene Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Taysha Gene Therapies Q3 2024 Earnings Date

Currency：USDNov 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.65M
1.79M
+139.36K
Beat Est.
-65.26%
-62.33%
+8.45%
EPS
-0.09
-0.10
-0.01
Miss Est.
+90.43%
+89.25%
-12.36%
Analyst Rating
Strong Buy

Nov 30, 2024

Taysha Gene Therapies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.492M--
--2024/Q4-- / 2.053M--
Nov 13, 20242024/Q31.788M / 1.649M--
Aug 12, 20242024/Q21.112M / 2.632M--
May 14, 20242024/Q13.411M / 2.305M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.492M--
--2024/Q4-- / 2.053M--
Nov 13, 20242024/Q31.788M / 1.649M--
Aug 12, 20242024/Q21.112M / 2.632M--
May 14, 20242024/Q13.411M / 2.305M--

Unlock Free Earnings Estimates

Taysha Gene Therapies Earnings Reports

  • Taysha Gene Therapies | 10-Q: Q3 2024 Earnings Report

    Nov 13 16:44 ET

  • Taysha Gene Therapies | 8-K: Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 13 16:17 ET

  • Taysha Gene Therapies | 10-Q: Q2 2024 Earnings Report

    Aug 12 08:36 ET

  • Taysha Gene Therapies | 8-K: Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 12 08:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data